Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TS ID 10725]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Bipolar disorder: assessment and management (extraordinary review)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC